Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
The Reaction To Valsartan Impurities: More Scrutiny, More Testing And Tighter Limits
Potent Carcinogens Stir Up Anxieties Over Unknown Unknowns In Pharmaceutical Process Chemistry
Feb 11 2019
•
By
Bowman Cox
More from Compliance
More from Pink Sheet